Invesaro

Stocks ARDT Financial statements

Financial statements

Ardent Health, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 4 fiscal years, taken from the XBRL data Ardent Health, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2022FY2024FY2024FY2025
Revenue5,1305,4095,9666,324
General and administrative75.3115132141
Pre-tax income311152363286
Income tax46.122.663.456.2
Net income to minority interests76.575.189.494.3
Net income18953.9210136
EPS, basic1.500.431.590.96
EPS, diluted1.500.431.580.96
Shares, basic (weighted)126126132141
Shares, diluted (weighted)126126133141

Balance sheet

FY2022FY2024FY2024FY2025
Cash and equivalents456438557710
Receivables775743686
Inventory105115119
Other current assets222304432
Total current assets1,6181,8332,059
Property, plant and equipment811862936
Goodwill845845852879
Intangible assets12.4
Other non-current assets147143112
Total assets4,7324,9565,290
Accounts payable475401458
Short-term debt18.69.2323.4
Total current liabilities9949451,047
Long-term debt1,1681,0861,076
Lease liabilities1,1411,165
Other non-current liabilities7634.776.6
Total liabilities3,6493,4343,605
Total debt1,1871,1141,116
Paid-in capital0754788
Retained earnings155366502
Other comprehensive income18.69.74-3.61
Shareholders' equity6711,1311,288
Minority interests404390398
Total equity1,0401,0751,5211,686
Total liabilities and equity4,7324,9565,290
Shares outstanding0143143

Cash flow statement

FY2022FY2024FY2024FY2025
Net income265129300230
Depreciation and amortization138141146156
Deferred income tax46.14.7523.343.6
Change in receivables-17.2-1814059.2
Change in inventory4.671.67-9.41-3.15
Cash from operations-38.4222315471
Acquisitions00-35.5-2.5
Cash from investing46.6-138-220-214
Debt issued0.886.623.60
Debt repaid-17.3-13.6-108-7.99
Dividends paid-17500
Cash from financing-270-10224.6-103
Net change in cash-262-18.5119153
Income taxes paid55.819.441.636.5

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $10.54 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Pre-tax margin3.2%Pre-tax income / revenue.
Net margin1.2%Net income / revenue.
Operating cash flow margin8.0%Cash from operations / revenue.
Effective tax rate18.9%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)5.8%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)1.5%Net income / average total assets.
D&A / revenue2.6%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y6.0%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y7.2%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y-35.4%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y-10.4%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y-39.2%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y-13.8%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y49.4%Operating cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y13.8%Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y6.7%Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y6.6%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y3.9%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio2.10xCurrent assets / current liabilities.
Quick ratio1.45x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.74x(Cash + short-term investments) / current liabilities.
Debt / equity0.82xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets20.9%Total debt / total assets.
Liabilities / assets67.0%Total liabilities / total assets.
Net debt$377.3MTotal debt - cash - short-term investments. Negative means more cash than debt.
Working capital$1.08BCurrent assets - current liabilities.
Goodwill and intangibles / assets16.7%(Goodwill + intangible assets) / total assets.
Tangible book value$471.3MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover1.21xRevenue / average total assets.
Fixed asset turnover6.96xRevenue / average property, plant and equipment.
Receivables turnover9.20xRevenue / average receivables.
Days sales outstanding40 days365 x average receivables / revenue.

Per share

MetricValueHow it is calculated
EPS, diluted$0.55Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$44.78Revenue / diluted weighted shares.
Operating cash flow per share$3.60Cash from operations / diluted weighted shares.
Book value per share$9.52Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$3.32Tangible book value / shares outstanding.
Cash per share$5.11(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$1.49BShare price x shares outstanding.
Enterprise value$1.86BMarket cap + total debt - cash - short-term investments.
P/E19.0xMarket cap / net income. Only when net income is positive.
P/S0.23xMarket cap / revenue.
P/B1.10xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book3.15xMarket cap / tangible book value, when positive.
P/OCF2.89xMarket cap / cash from operations, when positive.
EV/Sales0.29xEnterprise value / revenue.
Earnings yield5.3%Net income / market cap (the inverse of P/E).
What was Ardent Health, Inc.'s revenue in fiscal 2025?

Ardent Health, Inc. reported revenue of $6.32B for fiscal 2025, 6% higher than the year before.

Was Ardent Health, Inc. profitable in fiscal 2025?

Yes. Net income was $135.8M, a net margin of 2.1%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Ardent Health, Inc.